Article Versions Notes

Illini O, Saalfeld FC, Christopoulos P, Duruisseaux M, Vikström A, Peled N, Demedts I, Dudnik E, Eisert A, Hashemi SMS, et al. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International Journal of Molecular Sciences. 2024; 25(7):3992. https://doi.org/10.3390/ijms25073992

Illini, Oliver, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M. S. Hashemi, and et al. 2024. "Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis" International Journal of Molecular Sciences 25, no. 7: 3992. https://doi.org/10.3390/ijms25073992

Illini, O., Saalfeld, F. C., Christopoulos, P., Duruisseaux, M., Vikström, A., Peled, N., Demedts, I., Dudnik, E., Eisert, A., Hashemi, S. M. S., Janzic, U., Kian, W., Mohorcic, K., Mohammed, S., Silvoniemi, M., Rothschild, S. I., Schulz, C., Wesseler, C., Addeo, A., ... Wermke, M. (2024). Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International Journal of Molecular Sciences, 25(7), 3992. https://doi.org/10.3390/ijms25073992